Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • COVID UPDATE: Russian Vaccine enters Phase III trials: A Sputnik moment or a Russian Roulette?

Novel cell membrane model- a step to uncover protein regulation

Can marine phytoplankton grow under extremely low light condition?

COVID UPDATE: Russian Vaccine enters Phase III trials: A Sputnik moment or a Russian Roulette?
  • BiotechToday
  • India
  • World

COVID UPDATE: Russian Vaccine enters Phase III trials: A Sputnik moment or a Russian Roulette?

bioxone September 27, 2020September 27, 2020

Team BioXone

Covid-19 continues to spread globally like wildfire. The vaccine in development is the only hope for prevention and containment. Every capable country is into investing millions to fast track development of vaccines, telescoping the duration of clinical trials from years to months.

Russia launched its home-brewed vaccine – SPUTNIK V, in August, based on Adenovirus vectors. India too has agreed to take on the Russian vaccine after clinical trials on Indians. For a vaccine to be pre-qualified for global use by the World Health Organization (WHO) it requires data for all three phases of a clinical trial (Phase I-III). Phase III is crucial to know the safety and efficacy of the vaccine. 

During Phase I and II, there are reports that about 14% of 300 volunteers who received the vaccine have had mild self-limiting side-effects (weakness, muscle pain, and rise in temperature and chills). The dose for Phase III will be administered 21 days apart, the trial is in 40,000 volunteers, and results are expected by end of October 2020. 

The sudden response of euphoria among those affected is a matter of urgent response, as people getting discharged after phase II, might not take any preventions later. Experts say that SPUTNIK V has entered a trial that will evaluate its worth or term it as a Russian Roulette.

Read more about biosciences on bioXone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged china corona vaccine corona vaccine status corona vaccine update in hindi corona vaccine update in india corona vaccine update news CORONAVIRUS coronavirus vaccine latest news coronavirus vaccine update news coronavirus vaccine usa covid coronavirus vaccine india COVID INDIA news on coronavirus vaccine PHASE III Russian Vaccine Safety Sputnik V unlock 5.0 unlock 5.0 guidelines when corona vaccine available in india

One thought on “COVID UPDATE: Russian Vaccine enters Phase III trials: A Sputnik moment or a Russian Roulette?”

  1. Pingback: Cat Que virus | Another pandemic in India! | ICMR - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Can marine phytoplankton grow under extremely low light condition?

bioxone September 27, 2020

–Shrayana Ghosh, Amity University Kolkata. The earlier belief that phytoplankton in the artic marines are unable to grow until the snow and ice cover melts due to insufficient transmission of sunlight is now being challenged by a possible theory that suggests that marine algae may be capable of growing under extremely low irradiance also highlighting […]

phytoplankton

Related Post

  • BiotechToday
  • World

Extracellular vesicles for shuttling small RNAs and proteins

bioxone June 29, 2021June 29, 2021

Aparna Pandey, IILM Academy of Higher learning and Education, Greater Noida Extracellular vesicles are small sheaths particles derived from various cell types. Extracellular vesicles are lipid bilayer-enclosed, cytosol-containing spheres that are liberated by all eukaryotes and prokaryotic cells into the extracellular environment. Small RNAs plays an important role in different cellular processes like differentiation in […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Enhancing kidney tissue formation & neovascularisation using 3D vascular scaffold.

bioxone February 15, 2021February 15, 2021

Rohit Bhattacharjee, Amity University, Kolkata. It has always been a critical challenge to establish an adequate vascularisation of 3D bioengineered tissues. A vascular scaffold using the vascular corrosion casting technique was fabricated earlier that provided a lookalike 3D geometry of native kidney vasculature. In this, the collagen vascular scaffold with the restricted release of VEGF […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Polypharmacy & Drug-Drug Interactions

BioTech Today August 2, 2021August 1, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi Polypharmacy: Polypharmacy refers to the usage of several medicines at the same time. It is the combination of drugs, and has become a frequent practice in modern medicine, particularly among the elderly and patients with complicated illnesses. When two or more drugs are taken at the same time, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy